BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12601311)

  • 1. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
    Zimmer LA; McCook B; Meltzer C; Fukui M; Bascom D; Snyderman C; Townsend DW; Johnson JT
    Otolaryngol Head Neck Surg; 2003 Feb; 128(2):178-84. PubMed ID: 12601311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
    Razfar A; Branstetter BF; Christopoulos A; Lebeau SO; Hodak SP; Heron DE; Escott EJ; Ferris RL
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):120-5. PubMed ID: 20157055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
    Kim SJ; Lee TH; Kim IJ; Kim YK
    Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
    Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
    J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positron emission tomography-computed tomography with (18)F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with tyroglobulin levels].
    Mariscal Labrador E; García Burillo A; Castell-Conesa J; Obiols Alfonso G; Kisiel González N; Barios Profitós M; Aguadé-Bruix S; Mesa Manteca J
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):146-51. PubMed ID: 22726673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
    Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma.
    Frilling A; Görges R; Tecklenborg K; Gassmann P; Bockhorn M; Clausen M; Broelsch CE
    Surgery; 2000 Dec; 128(6):1067-74. PubMed ID: 11114644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
    Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma.
    Nahas Z; Goldenberg D; Fakhry C; Ewertz M; Zeiger M; Ladenson PW; Wahl R; Tufano RP
    Laryngoscope; 2005 Feb; 115(2):237-43. PubMed ID: 15689742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer--indications and opportunities for positron emission tomography/computed tomography imaging.
    Abraham T; Schöder H
    Semin Nucl Med; 2011 Mar; 41(2):121-38. PubMed ID: 21272686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
    Skoura E; Rondogianni P; Alevizaki M; Tzanela M; Tsagarakis S; Piaditis G; Tolis G; Datseris IE
    Nucl Med Commun; 2010 Jun; 31(6):567-75. PubMed ID: 20335822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive endotracheal lesions of thyroid cancer.
    Ahmed M; Saleem M; Al-Arifi A; Almahfouz A; Mahasin Z; Al-Sobhi S; Ingemansson S; Taibah K
    J Laryngol Otol; 2002 Aug; 116(8):613-21. PubMed ID: 12389690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET-CT in recurrent ovarian cancer: initial observations.
    Pannu HK; Bristow RE; Cohade C; Fishman EK; Wahl RL
    Radiographics; 2004; 24(1):209-23. PubMed ID: 14730047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.